Literature DB >> 25965702

Atypical exanthems associated with Parvovirus B19 (B19V) infection in children and adults.

Francesco Drago1, Giulia Ciccarese1, Francesco Broccolo2, Sanja Javor1, Aurora Parodi1.   

Abstract

Parvovirus B19 (B19V) infection may differently manifest in various age groups. Erythema infectiosum ('fifth disease') is the most common B19V manifestations in children. Arthralgias and arthritis, with or without rash, are common manifestations of B19V infection in adults. Pruritus is usually present in adults and children. However, other cutaneous manifestations and atypical exanthems have been occasionally reported during B19V infection. To investigate the putative role of B19V infection in atypical exanthems, a total of 390 consecutive patients with atypical exanthems were analysed for B19V infection by determining B19V IgG and IgM antibodies titres in acute and convalescent phase as well as B19V DNA detection in serum by polymerase chain reaction (PCR). Atypical exanthems resulted related to B19V infection in 6 of the 120 pediatric (5%) and 14 of the 270 adult patients (5.2%). In conclusion this study reveals that atypical exanthems related to B19V infection are possible both in children and in adults, with a similar prevalence.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  arthralgias; enanthem; exanthem; maculo-papular eruption; parvovirus B19; parvovirus B19 viremia; purpuric lesions

Mesh:

Substances:

Year:  2015        PMID: 25965702     DOI: 10.1002/jmv.24246

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

Review 1.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations.

Authors:  F Drago; G Ciccarese; A Rebora; S I Muzic; A Parodi
Journal:  Br J Dermatol       Date:  2020-07-13       Impact factor: 11.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.